Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksBuy Cadila Healthcare; target of Rs 460: Edelweiss

    Buy Cadila Healthcare; target of Rs 460: Edelweiss

    Edelweiss is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 31, 2017.

    February 02, 2017 / 15:55 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Edelweiss' research report on Cadila Healthcare

      Cadila Healthcare’s (CDH) Q3FY17 earnings disappointed as US base business suffered from product specific shipment halts and price erosion. Revenue, EBITDA and PAT fell 1%, 32% and 35% YoY, respectively. R&D expense spiked following 30 new filings with 6 FTFs. With this, CDH now has maximum pending ANDA approvals (at 200) among peers.

      OutlookWith Moraiya on the cusp of re-audit beginning next week and resolution of its Warning Letter in sight, the company is geared to deliver best-in-class US growth among peers led by long pipeline (consisting niche launches) that will in turn drive strong earnings growth over FY17-19E. Maintain ‘BUY’.
      For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

      Read More Read More

      first published: Feb 2, 2017 03:55 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347